Skip to content
OpenCapital
Get started

CONMED CNMD Net debt / EBITDA

Net debt / EBITDA at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
1×+0.5×
Stryker logo
StrykerSYK
1.9×-1.3×
Boston Scientific logo
Boston ScientificBSX
-0.1×-2.9×
Vericel logo
VericelVCEL
-0.5×-5.5×
OSI Systems logo
OSI SystemsOSIS
2.7×+1.1×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
3.1×+0.6×

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Calculated from CONMED’s reported figures.

net debt/ebitda=5×

Based on the most recent quarter.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's net debt / EBITDA?
CONMED (CNMD) reported net debt / EBITDA of 5× in Q1 2026.
How has CONMED's net debt / EBITDA changed year-over-year?
CONMED's net debt / EBITDA increased by 36.5% year-over-year, from 3.7× to 5×.
What is the long-term trend for CONMED's net debt / EBITDA?
Over 5 years (2020 to 2025), CONMED's net debt / EBITDA has grown at a -6.9% compound annual growth rate (CAGR), from 7.8× to 5.5×.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.